HeartSciences (HSCS) Profit After Tax (2021 - 2026)

HeartSciences has reported Profit After Tax for 6 years, with the latest figure at -$2.0 million in Q1 2026.

• For the quarter ending Q1 2026, Profit After Tax rose 21.73% year-over-year to -$2.0 million; the trailing twelve-month figure through Jan 2026 stood at -$8.5 million (changed 0.37% YoY), and the FY2025 full-year result was -$8.8 million, down 32.7% from the prior year.
• Profit After Tax for Q1 2026 stood at -$2.0 million, up from -$2.4 million in the prior quarter.
• The five-year high for Profit After Tax was -$1.2 million in Q1 2022, with the low at -$2.5 million in Q1 2025.
• Historically, Profit After Tax has averaged -$1.8 million across 5 years, with a median of -$1.8 million in 2024.
• Annual changes were most pronounced in 2022 — Profit After Tax plunged 213.5% — and 2026, when it increased 21.73%.
• HeartSciences' Profit After Tax stood at -$1.8 million in 2022, then rose by 3.22% to -$1.7 million in 2023, then declined by 19.13% to -$2.1 million in 2024, then declined by 12.86% to -$2.4 million in 2025, then rose by 15.55% to -$2.0 million in 2026.
• The last three Profit After Tax figures came in at -$2.0 million (Q1 2026), -$2.4 million (Q4 2025), and -$2.1 million (Q3 2025), per Business Quant data.